Skip to main content
Deloitte at Reuters Pharma 2025
Wednesday, 9 April 2025 9:00 a.m. CET

In-person - Event

Event language: English

9 - 11 Apr. 2025

09:00 a.m. CET

Deloitte at Reuters Pharma 2025

Designed to foster collaboration and drive meaningful change in healthcare, Reuters Pharma 2025 convenes pharmaceutical leaders, experts, and policymakers to address the life sciences and healthcare industry’s most pressing challenges.

About The Reuters Pharma 2025 event

Deloitte is proud to be a sponsor at Reuters Pharma 2025, and we look forward to bringing fresh perspectives to the evolving commercial landscape in the pharma industry.

Building on a rich 23-year legacy, Reuters Pharma is the global collaborative network for leading pharma innovators. This year’s event, scheduled for 9-11 April 2025, offers a comprehensive and reimagined agenda featuring over 70 on-stage sessions, interactive hackathons, and deep-dive roundtables. With over 1,000 industry leaders, stakeholders, and experts expected to attend, the event will provide unparalleled opportunities for conversations shaping the future of pharmaceuticals.

Find out more about Reuters Pharma 2025 and key Deloitte sessions here:

Visit the event website

Deloitte’s presence at Reuters Pharma 2025

Join us at Reuters Pharma 2025 to engage with industry experts, gain actionable insights, and be a part of the conversation that redefines the pharmaceutical landscape.

Date: 9 April 2025

Time: 3:10 PM – 4:15 PM CEST

Description: The pharmaceutical landscape is evolving at an unprecedented pace, and at its heart lies the need for impactful customer engagement. This workshop will explore the future of customer engagement in pharma, dissecting why traditional capabilities like segmentation, targeting, and omnichannel strategies, often siloed in the past, are now poised to deliver on their full potential.

This will be an interactive session where we will collectively reimagine customer engagement in the pharmaceutical industry and unlock the power of a truly connected and personalized approach.

Key discussion themes:

  • The Shifting Landscape: The driving forces behind this evolution, from technological advancements in AI, data analytics, and personalization, and the increasing demand for interconnected and coordinated approaches.
  • Breaking Down Silos: How integrating previously isolated capabilities can create a cohesive and impactful customer engagement strategy.
  • The Power of Personalization: How advanced data analytics and AI are enabling a new era of hyper-personalization, leading to more meaningful and influential customer interactions.
  • From Vision to Action: How leading pharma companies are leveraging these advancements to overcome past challenges and drive superior commercial results.

Moderator:

  • Aditya Kudumala, Global Life Sciences Strategy and Gen AI leader, Deloitte

Date: 9 April 2025

Time: 5:25 PM – 6:15 PM CEST

Description: This panel discussion will explore how to build an effective cross-functional customer engagement team by integrating skills from medical, marketing, commercial, and tech functions. It will focus on empowering teams with advanced skills and data-driven strategies, avoiding siloed thinking, and establishing long-term KPIs that promote collaboration and align with company goals.

Panelists:

  • Carlos Guzmán Quilo, Director, Global Medical Communication & Content, Vaccines and Antivirals (CMAO), Pfizer
  • Michelle Melka, Director Global Product Strategy, Digital Capabilities and Transformation, BioMarin Pharmaceuticals
  • Federico Baldelli, Global Associate Director Omnichannel & Content, Almirall
  • Benjamin Head, Customer Experience Activation Director, Novartis

Moderator: 

  • Inaki Moreno Narbona, Life Sciences & Health Care Industry leader, Deloitte Spain

Client Events

Time: 7:00 PM-9:30 PM CEST

Date: 9 April 2025

Deloitte will host a networking reception on the first day of the event—an opportunity to engage with industry colleagues and Deloitte leaders.

Deloitte will host exclusive one-on-one sessions with industry leaders, experts, and partners to explore strategic partnerships and continue conversations around the latest advancements shaping the future of pharmaceuticals.

Meet our leaders

Todd Konersmann

Deloitte - Global
Todd Konersmann is the Global Life Sciences Sector Leader for Deloitte Global. In this role, he guides and advises Deloitte Life Sciences leaders across the globe to ensure our professionals can bring the best services and solutions to their clients in the life sciences sector. Todd is a principal in Deloitte Consulting LLP’s Life Sciences and Health Care practice and has led client teams in APAC, EMEA, and North America. He has previously served as the national leader for the Life Sciences Technology practice. With more than 25 years of experience, Todd has led large global technology and business transformation programs for some of our largest and most notable clients in over 25 countries. Todd has a passion for continuous learning, encourages curiosity and teaming while focusing on our purpose "to improve health for all."

Inaki Moreno Narbona

Deloitte - Global
Iñaki is the partner-in-charge of the Life Sciences and Healthcare sector at Deloitte Spain. He joined the firm in 2015 to develop the pharma and healthcare sector within Consulting. Throughout his professional career, he has led the creation of an omnichannel marketing services hub for the pharmaceutical industry from Deloitte Digital, which is widely connected to Deloitte's international network. He has also led and participated in various transformation projects within the healthcare field. Previously, he worked in the pharmaceutical and consumer goods sectors for client companies and also in consulting, following his studies in Industrial Engineering at ICAI.

Aditya Kudumala

Deloitte - Global
Aditya is the Leader of Global Consulting Services Life Sciences & Health Care Global Market Play. Leading the Life Sciences Strategy, AI/GenAI, and innovation businesses to deliver insights and innovative solutions to drive value for organizations. His primary focus has been delivering strategy, AI/GenAI, products and technology-enabled business and digital transformation initiatives to deliver strategic outcomes.

Patricia Gee

Deloitte - Global
Patricia leads Deloitte’s Future of Health initiative in Switzerland. She has spent over 15 years in the life sciences and health care industry, bringing together cross-sector experience in biopharma, payer, provider and capital markets. She focuses on driving sustainable value, growth and innovation for leading life sciences clients by creating commercial portfolios and business unit strategies, designing and developing customer-centric solutions and deploying commercial excellence programs.

Explore our sponsorship and related insights

2025 life sciences outlook

Despite industry uncertainties, life sciences execs expect their organizations to adapt, grow, and generate value.

Life Sciences and Healthcare Predictions 2030

The predictions provide a mostly optimistic and deliberately provocative view of 2030, to help organisations prepare for the changes ahead.
Collection

2025 global health care outlook

Health system leaders in various parts of the world intend to drive efficiencies, boost productivity, and improve patient engagement in 2025, according to the results of a survey conducted by the Deloitte US Center for Health Solutions.

The Deloitte Health Equity Institutes

Learn more about the specific actions the Deloitte Health Equity Institute is taking to foster health equity for all.
Perspective
2 minute read